* Ocugen Inc OCGN.OQ OCGN.O is expected to show a rise
in
quarterly revenue when it reports results on November 8 for the
period ending September 30 2024
* The Malvern Pennsylvania-based company is expected to
report
revenue of $300 thousand, according to the mean estimate from 4
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Ocugen Inc is for a loss
of 5
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ocugen Inc
is
6.50, above its last closing price of $0.95.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.05 -0.05 -0.04 Beat 25
Mar. 31 2024 -0.06 -0.06 -0.05 Beat 21
Dec. 31 2023 -0.06 -0.03 Beat 53.8
Sep. 30 2023 -0.07 -0.07 -0.06 Beat 14.3
Jan. -0.07 -0.07 -0.08 Missed -9.1
1 0001
Mar. 31 2023 -0.11 -0.11 -0.07 Beat 35.2
Dec. 31 2022 -0.10 -0.10 -0.10 Met -2
Sep. 30 2022 -0.10 -0.10 -0.10 Met -1.7
This summary was machine generated November 6 at 14:14 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)